19 June 2013
Keywords: amgen, sensipar, oked, fda, world, biotechnology, leader
Article | 15 March 2004
World biotechnology leader Amgen has received US Food and Drug Administration approval for its Sensipar (cinacalcet), following a
priority review. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 March 2004
© 2013 thepharmaletter.com